Please ensure Javascript is enabled for purposes of website accessibility

OraSure receives funding to further COVID-19 test clearance

Just days after announcing that it had received a $205 million federal contract to provide COVID-19 InteliSwab tests, Bethlehem’s OraSure said the Biomedical Advanced Research Development Authority (BARDA) will provide up to $13.6 million in funding for the Company to obtain 510(k) clearance and CLIA waiver for their COVID-19 rapid test, InteliSwab, from the Food & Drug Administration. 

Writer Stacy Wescoe has her finger on the pulse of the business community in the Greater Lehigh Valley and keeps you up-to-date with technology and trends, plus what coworkers and competitors are talking about around the water cooler — and on social media. She can be reached at swescoe@bridgetowermedia.com or 610-807-9619, ext. 4104. Follow her on Twitter and on Facebook.

Business Journal Events

Health Care Summit

Thursday, August 18, 2022
Health Care Summit

Forty Under 40 Awards

Wednesday, September 14, 2022
Forty Under 40 Awards

Reader Rankings Awards

Monday, October 10, 2022
Reader Rankings Awards

Real Estate & Development Summit

Wednesday, October 12, 2022
Real Estate & Development Summit